| 注册
首页|期刊导航|中国临床药理学杂志|肝X受体抗动脉粥样硬化作用机制研究进展

肝X受体抗动脉粥样硬化作用机制研究进展

魏静 陈景瑞 苗琳 樊官伟

中国临床药理学杂志Issue(10):893-896,4.
中国临床药理学杂志Issue(10):893-896,4.DOI:10.13699/j.cnki.1001-6821.2015.10.038

肝X受体抗动脉粥样硬化作用机制研究进展

Research progress on antiatherosclerosis mechanism of liver X receptors

魏静 1陈景瑞 1苗琳 1樊官伟1

作者信息

  • 1. 天津中医药大学 中医药研究院 药理毒理部,天津 300193
  • 折叠

摘要

Abstract

Liver X receptor is a ligand -activated transcription factor of nuclear receptor super family .It played a key role in the regulation of lipid metabolism.In the past decade , numerous studies show that liver X receptor are involved in a series of physiological processes such as meta-bolism and inflammation by activating or inhibiting its target genes that are so closely linked with cardiovascular diseases .In recent years, a large number of studies have shown that liver X receptor are increasingly prominent in fighting against atherosclerosis . In this paper , we will review the targets of the LXR pathways on the pathogenesis of atherosclerosis.

关键词

肝X受体/动脉粥样硬化/脂质代谢/炎症

Key words

liver X receptor/atherosclerosis/lipid metabolism/inflammation

分类

医药卫生

引用本文复制引用

魏静,陈景瑞,苗琳,樊官伟..肝X受体抗动脉粥样硬化作用机制研究进展[J].中国临床药理学杂志,2015,(10):893-896,4.

基金项目

国家自然科学基金资助项目(81273891);教育部“创新团队发展计划”基金资助项目 ()

中国临床药理学杂志

OA北大核心CSCDCSTPCD

1001-6821

访问量0
|
下载量0
段落导航相关论文